Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026)
Tyra Biosciences (TYRA) posted Prepaid Assets of $11.1 million for Q1 2026, up 18.0% on a QoQ basis from $9.4 million in Q4 2025, and up 98.24% year-over-year from $5.6 million in Q1 2025.
Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026) Analysis & Trends
Tyra Biosciences' Prepaid Assets history runs 7 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- Quarterly Prepaid Assets rose 98.24% year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.1 million (up 98.24% YoY) and the FY2025 annual result came in at $9.4 million, up 56.87% from the prior year.
- Prepaid Assets was $11.1 million for Q1 2026 at Tyra Biosciences, up from $9.4 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $11.1 million in Q1 2026 and bottomed at $1.5 million in Q1 2022.
- A 5-year average of $6.3 million and a median of $6.0 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 528.32% — and 2024, when it plunged 42.66%.
- Tyra Biosciences' Prepaid Assets stood at $6.1 million in 2022, then surged by 35.01% to $8.2 million in 2023, then retreated by 26.58% to $6.0 million in 2024, then soared by 56.87% to $9.4 million in 2025, then increased by 18.0% to $11.1 million in 2026.
- Business Quant data shows TYRA's Prepaid Assets at $11.1 million in Q1 2026, $9.4 million in Q4 2025, and $6.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.15 Mn |
| Dec 31, 2025 | 9.45 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 8.32 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 8.98 Mn |
| Jun 30, 2023 | 8.33 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 6.08 Mn |
| Sep 30, 2022 | 4.26 Mn |
| Jun 30, 2022 | 2.19 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | 678,000.00 |
| Dec 31, 2020 | 57,000.00 |